Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04305366 · ClinicalTrials.gov registry record
MicroRNA Markers in Head and Neck Cancers
A clinical trial of Squamous Cell Carcinoma of Head and Neck, sponsored by University of Colorado, Denver.
- Active
- Registry status
- 225
- Enrollment target
- 1
- Study location
NCT04305366 is a study of Squamous Cell Carcinoma of Head and Neck that is active but no longer recruiting, run by University of Colorado, Denver. The registered enrollment target is 225 participants, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04305366, a study of Squamous Cell Carcinoma of Head and Neck, is active but no longer recruiting, sponsored by University of Colorado, Denver.
- ACTIVE NOT RECRUITING
- Registry status
- 225 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the presence of miRNA markers in saliva, blood, FNA and tissue specimens in patients with and without head and neck cancer and evaluate whether these miRNA markers can provide prognostic or diagnostic clinical significance in the treatment of head and neck cancer patients.
Conditions Studied
Interventions
- OTHER Tissue collection
Study Locations (1)
Colorado
- University of Colorado Cancer Center - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 225 participants |
| Start Date | 2012-11-16 |
| Est. Completion | 2027-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04305366
The ClinicalTrials.gov registry entry for NCT04305366 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 225 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (37% higher). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Squamous Cell Carcinoma of Head and Neck appearing as the primary indexed condition, and to 1 intervention - of which Tissue collection is the first listed.
NCT04305366 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT04305366 about?
NCT04305366 is a clinical study titled "MicroRNA Markers in Head and Neck Cancers". The purpose of this study is to investigate the presence of miRNA markers in saliva, blood, FNA and tissue specimens in patients with and without head and neck cancer and evaluate whether these miRNA markers can provide prognostic or diagnostic clinical significance in the treatment of head and neck...
What is the current status of trial NCT04305366?
This trial is currently active not recruiting. The enrollment target is 225 participants. The study started on 2012-11-16. Estimated completion is 2027-02.
What conditions does trial NCT04305366 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma of Head and Neck.
What interventions are being tested in trial NCT04305366?
The interventions under investigation include: Tissue collection (OTHER).
Who is sponsoring clinical trial NCT04305366?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04305366 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma of Head and Neck
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
RECRUITING · Phase 1
-
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study of MGC026 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
RECRUITING · Phase 2
-
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RECRUITING · Phase 3
-
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.